| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae11220a1bbe5ab02d787607c5422004 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00 |
| filingDate |
2015-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7cf62288379b245e22154524d282ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95dfacaf217eb1ae78f0aee8d477359f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fda8de0d79f3b8ac4fd2155215e5d8a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b67390c1a84d371068d2129dcfb4ce6a |
| publicationDate |
2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015226545-A |
| titleOfInvention |
Method for urine detection of bladder cancer |
| abstract |
The present invention is directed to diagnosis of bladder cancer, more specifically, detection in a urine sample of metastatic bladder cancer. The detection method of the present invention can determine the grade of a detected tumor through the use of a DNA chip designed for this purpose. According to the present invention, the detection is via the labeling of the total amount of DNA in the patient's urine and the detection in this DNA of chromosomal sequences contained in loci potentially potentially affected by genetic abnormalities. Obtained. [Selection figure] None |
| priorityDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |